Spandidos Publications

19th World Congress on Advances in Oncology
and
17th International Symposium on Molecular Medicine

October 9-11, 2014
Metropolitan Hotel, Athens, Greece

The list is incomplete and will be updated periodically:

Aarestrup BJV: - (Brazil) - Prophylaxis with atorvastatin, pentoxifylline and trans-caryophyllene in chemotherapy-induced leukopenia with 5-fluorouracil in experimental model in rats.

Aarestrup FM: - (Brazil) - Evaluation of administration of atorvastatin in the prevention of side effects in Wistar rats undergoing chemotherapy with 5-FU.

Addison CL: - (Canada) - Focal adhesion kinase inhibition sensitizes EGFR wild-type non-small cell lung cancer to EGFR inhibitors.

Agostinelli E: - (Italy) - Potentiation of cytotoxicity of spermine metabolites induces apoptosis in tumor cells: New approaches in cancer therapy.

Ährlund-Richter L: - (Sweden) - A developmental approach to analyze neuroectodermal child cancer in matching human microenvironment in vivo.

Akoum A: - (Canada) - Tumour – Abnormal response to ovarian hormones in endometriosis: A new possible pathway underlying inflammation and abnormal tissue growth.

Al-Nedawi K: - (Canada) - Microvesicles in cancer: An intercellular communication mode and source for biomarkers.

Alexopoulos L: - (Greece) - Multiplex phopshoproteomics for the construction of signaling pathways.

Allam HM: - (France) - Abnormal response to ovarian hormones in endometriosis: A new possible pathway underlying inflammation and abnormal tissue growth.

Amsterdam A: - (Israel) - Localization of the stem cell markers LRG5 and Nanog and the oncogenic c-kit suggests a new approach to the treatment of pancreatic cancer.

Arciello M: - (Italy) - Altered copper homeostasis: an understimated player in metabolic disorders.

Arisan ED: - (Turkey) - mTOR signalling alters cell fate following inhibition of cyclin-dependent kinases due to androgen receptor status in prostate cancer cells.

Arnason T: - (Canada) - Multiple drug resistance (MDR) detection and biomarker reversal in companion canines.

Baj-Krzyworzeka M: - (Poland) - Tumour – derived microvesicles as important players in tumour - immune cells interactions.

Balsano C: - (Italy) - Novel findings in NAFLD and HCV-related steatosis.

Bankovic J: - (Serbia) - The role of tetraspanine 14 and cadherine 12 in non-small cell lung cancer progression.

Baron B: - (Malta) - Characterising the biological function of E4TF1-binding methyltransferase (EBM) in cancer.

Basu A: - (India) - Host pathogen interaction in Japanese Encephalitis: from bench to bedside.

Bauer N: - (Germany) - Establishment of hypoxia induction in an in vivo animal replacement model for experimental evaluation of pancreatic cancer.

Bellis SL: - (USA) - New tumor survival mechanisms mediated by the tumor glycome.

Bersinger NA: - (Switzerland) - Ovarian cancer markers for endometriosis: Is HE-4 superior to CA-125?

Bhattacharyya A: - (India) - Regulation and role of Siah1in Helicobacter pylori-infected gastric epithelial cancer cells.

Bi X-L: - (China) - Using nano-technology towards cancer treatment.

Blackstock W: - (USA) - Novel imaging for the management of esophageal cancer.

Blalock W: - (Italy) - Functional proteomics as a means to define signal transduction events in cancer.

Blondel M: - (France) - A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus.

Borawska MH: - (Poland) - The interaction of bee bread and Royal Jelly with temozolomide in human Glioblastoma multiforme (U87MG) and normal human astroglia (SVGp12) cell lines.

Bouraoui A: - (Tunisia) - Purified fractions from Marine organisms inhibit three human cancer cell lines proliferation.

Bouraoui A: - (Tunisia) - Sea urchin embryos as a model organism for studying anti-mitotic agents and multidrug efflux transporters modulators.

Brieger A: - (Germany) - Relevance of MLH1 deficiency for reduced metastasis of colorectal cancer.

Brieger J: - (Germany) - Prohibition of tumor cell migration by combined hnRNPK-knock down and irradiation.

Buturovic L: - (USA) - Personalized medicine in oncology: a critical assessment and a path forward.

Byrne JA: - (Australia) - The target and the targeted- Tumor protein D52 (TPD52) and cancer.

Campos MIC: - (Brazil) - The potential of Trans-caryophyllene, molecule extracted from the oil of the Copaífera langsdorffii tree, in the prevention of oral mucositis and reduction of systemic inflammatory mediators in rats undergoing chemotherapy with 5-fluorouracil.

Camps J: - (Spain) - Impact of genomic copy number changes in colorectal cancer.

Cantile M: - (Italy) - Deregulation of lumbo-sacral HOX genes in cancer development and progression.

Capasso M: - (Italy) - Genome-wide analyses to understand the genetics and biology of neuroblastoma.

Castel H: - (France) - Signaling switch of the urotensin II receptor: Prototypic chemotaxic mechanism in glioma.

Chan FL: - (China) - Orphan nuclear receptors ERRs in prostate cancer: control of hypoxic growth and beyond.

Cater M: - (Australia) - Investigating metal aberrations in cancer: from basic science to therapeutic enquiry.

Celetti A: - (Italy) - New therapeutic perspectives in CCDC6 deficient NSCLC.

Chan Y-J: - (Taiwan) - The influence of human cytomegalovirus on colorectal cancer cells.

Chang JY: - (USA) - Cancer immunotherapy and stereotactic ablative radiotherapy: I SABR aiming for a cure.

Chaouch L: - (France) - Modifier genes in sickle cell anemia.

Chen H: - (China) - Transcriptional factors signaling in pancreatic cancer pathogenesis.

Chen L: - (China) - Establishment of MRI traceable oxaliplatin target-delivery nanoparticle conjugate and its therapeutic effects in gastric cancer.

Chen LL: - (USA) - Enhanced malate mitochondria metabolism in cancer and its application in cancer diagnosis.

Chen Q: - (China) - Different expression and significance of plasma non-coding RNAs in distant metastasis of gastric cancer patients.

Chen W: - (China) - Cytokines microenvironment deplete the pool of cancer stem cells to inhibit androgen independent prostate cancer.

Cheng N: - (China) - A Retrospective Cohort Mortality Study in Jingchuan of China - the largest nickel population in world.

Chevalier S: - (Canada) - Aberrant signaling in heterogeneous prostate tumors concur to disease progression.

Chi J-Y: - (Taiwan) - Pentraxin 3 is responsive to the activation of CCAAT/enhancer binding delta and promotes cancer progression in the tumor microenvironment.

Cho K-Y: - (Korea) - Stability regulation of Ras via the Wnt/beta-catenin signaling; implications in tumorigenesis.

Chung IS: - (Korea) - Inhibition of angiopoietin-1-induced angiogenesis and lymphangiogenesis by recombinant canstatin and 3-O-acetyloleanolic acid.

Cohen P: - (France) - Deeper insights into the deleterious role of ZNF217 in breast cancer.

Cohen Y: - (Israel) - Niche modulated and niche modulating genes in bone marrow cells.

Cohen S: - (Israel) - LUF6000, an A3 adenosine receptor allosteric modulator, mediates an anti-cancer effect.

Coley HM: - (UK) - Development of markers of chemoresponse in breast and ovarian cancers.

Corcos L: - (France) - Colon cancer progression: combined analysis of gene expression, pre-mRNA splicing and genomic alterations.

Croucher D: - (Australia) - Modelling of JNK network dynamics as a novel prognostic indicator in Neuroblastoma.

Czerniak BA: - (USA) - The genomic profile and molecular mechanisms of mucosal field effects initiating bladder carcinogenesis.

D’Assoro AB: - (USA) - Role of aurora-a mitotic kinase in promoting EMT, stemness and breast cancer metastases.

Da Silva T: - (Brazil) - DNA methylation in colorectal cancer.

Dalianis D: - (Sweden) - Human papillomaviruses and other biomarkers in tonsillar and base of tongue cancer and their influence on response to treatment.

David-Cordonnier M-H: - (France) - Targeting transcription factor at the DNA binding level: Inhibition of ERG and FLI1.

De la Mare J-A: - (South Africa) - Investigating the role of cancer stem cells and the microenvironment in metastasis and chemosensitivity in vitro.

De Nigris F: - (Italy) - Role of Polycomb complexes in bone sarcoma neoangiogenesis.

De Rosa M: - (Italy) - GSK-beta inhibition promotes mesenchymal to epithelial reverting transition in primary colon cancer cell cultures.

Delmas D: - (France) - Phospholipids as potential biomarkers of hepatocellular carcinoma progression.

Demetter P: - (Belgium) - The role of FHL-2 in colorectal cancer progression.

Demokan S: - (Turkey) - Saliva biomarkers as diagnostic tools in monitoring of head and neck cancer.

Demonacos C: - (UK) - Tetratricopeptide Repeat (TPR) proteins: Potential role in cancer immunotherapy.

Deng LW: - (Singapore) - A novel isoform of MLL5 as a potential therapeutic target for HPV-associated cervical cancer.

Deshane JS: - (USA) - Targeting tryptophan metabolism for lung cancer.

Dimanche-Boitrel M-T: - (France) - Necroptosis, a programmed cell death induced by TRAIL (TNF-related apoptosis inducing ligand).

Dimitrakakis C: - (USA) - The effects of androgens on breast tissue and carcinomas.

Dimitriadis E: - (Australia) - In vivo targeting of inflammation in endometrial cancer: a new treatment option.

Dimitroulakos J: - (Canada) - Enhancing EGFR targeted therapies in novel combination based therapeutic approaches.

Diolez P: - (France) - Non-invasive integrative analysis of cardiac energetics, translation to human heart in vivo.

Dol-Gleizes F: - (France) - Inhibition of VEGFR-3 in hepatocellular carcinoma as a new strategy of treatment.

Doxsey SJ: - (USA) - Novel asymmetric events during mitosis and their clinical consequences.

Du H: - (USA) - Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis.

Duesbery NS: - (USA) - MKK signaling in angiosarcoma.

Duraturo F: - (Italy) - Incomplete segregation of MSH6 mutations with phenotype of Lynch syndrome.

Durzyńska J: - (Poland) - IGF expression in HPV-related and HPV-unrelated human cancer cells.

Dussaule J-C: - (France) - New actors in chronic inflammation and fibrosis: the example of experimental kidney diseases.

Elmasry M: - (UK) - Management of advanced colorectal cancer, and the role of multidisciplinary team approach: A literature review and a tertiary centre experience.

Elshimali JY: - (USA) - Breast cancer stem cells, fundamental and clinical approach.

Epenetos AA: - (UK) - The dark side of stem cells.

Ergüven M: - (Turkey) - The prognostic and diagnostic significance of midkine levels in cancer from the side of cancer stem cells.

Farag M: - (UK) - Can aspirin and cancer prevention be ageless companions? A review of the literature.

Filep JG: - (Canada) - Lipid mediator targeting of neutrophil apoptosis for enhancing the resolution of inflammation.

Fishman P: - (Israel) - CF102 for the treatment of liver cancer: de-regulation of the Wnt signal transduction pathway.

Franken NA: - (The Netherlands) - PARP1-inhibition sensitizes combined hyperthermia-radiation and combined hyperthermia-cisplatin treatment of cervical carcinoma cells.

Fresco JR: - (USA) - The general features of the mechanism and its role in causing anemias and thalassemias via mutations in the β-globin gene.

Fresco JR: - (USA) - The role of the mechanism in causing mutations in proto-oncogenes.

Friant S: - (France) - X-linked centronuclear myopathy: insights into Myotubularin MTM1 function from yeast.

Fujita K: - (Japan) - Galectin-9 induces apoptosis of HCC in vitro and in vivo through up-regulation of miR-1246.

Fukuda T: - (Japan) - Coffee consumption delays the hepatitis and suppresses the inflammation related gene expression, and early phase of hepato-carcinogenesis in the Long-Evans Cinnamon rat.

Fukumoto M: - (Japan) - Establishment and characteristics of clinically relevant radio-resistant cancer cells which are resistant to conventional fractionated radiotherapy.

Fuqua SAW: - (USA) - Nuclear receptor mutations in breast cancer.

Fuxe J: - (Sweden) - Role of TGF-beta-induced epithelial-mesenchymal transitions in breast cancer invasion and metastasis.

Gao L: - (China) - The role of TIM-4 in NSCLC.

Gao X: - (China) - Vanishing lung syndrome in one famiiy: 5 cases with a 20-year follow-up.

Gavriilaki E: - (Greece) - Ossification of the cervical ligamentum flavum and osseous brown tumor: late manifestations of primary hyperparathyroidism misdiagnosed in a case of parathyroid carcinoma.

Gavriilaki E: - (Greece) - Venous versus arterial thrombosis in cancer: the role of antithrombotic prophylaxis.

Gerondakis S: - (Australia) - The role of NF-κB in regulatory T cell function.

Gibson L: - (USA) - Bone marrow microenvironment regulation of refractory leukemia.

Gillet G: - (France) - Non-canonical functions of Bcl-2 family proteins; therapeutic implications.

Glady G: - (France) - Preventive treatment of malignant cellular proliferations by a new method of immunogenetical therapy.

Gonen-Korkmaz C: - (Turkey) - Nuclear factor kappa B (NF-κB) silencing at lymph node metatatis of prostate cancer cell line (LNCaP).

Görmüs U: - (Turkey) - Proteomics for discovery of biomarkers.

Groisman I: - (France) - Translational control via 3’UTR in breast cancer development.

Grundström T: - (Sweden) - Regulation of diversification and affinity maturation of antibodies.

Guerrero-Preston R: - (USA) - Key tumor suppressor genes inactivated by ‘greater promoter’ methylation and somatic mutations in head and neck cancer.

Gupta RC: - (USA) - Exosomal drug delivery.

Gurzu S: - (Romania) - Particularities of maspin and mena expression in intestinal-type and diffuse gastric carcinoma.

Han C: - (Finland) - Modelling analysis in cardiac PET perfusion study.

Hashim O: - (Malaysia) - Serum and urinary inter-alpha trypsin inhibitor peptides as biomarker for prostate cancer.

Hatok J: - (Slovakia) - The expression of 90 apoptosis genes in relation to cellular drug resistance in endometrial carcinoma cells.

Hattori T: - (Japan) - Development of Barrett's esophagus - a novel GRCL (gut regenerative cell lineage) theory.

He J: - (China) - Antitumor activity of cobrotoxin in human lung adenocarcinoma A549 cells and transplantation in nude mouse.

Helguero LA: - (Portugal) - Expression and functionality of a histone cluster 2 variant in mammary epithelial and breast cancer cell proliferation and differentiation.

Helou K: - (Sweden) - Identification of a novel 4-protein prognostic panel in aggressive breast carcinoma.

Herbert C: - (France) - Anti-FGFR4 monoclonal antibody for the treatment of hepatocellular carcinoma.

Herr I: - (Germany) - Innovative new treatment options for advanced pancreatic cancer.

Heusschen R: - (Belgium) - Galectins in cancer: jacks of all trades.

Hilakivi-Clarke L: - (USA) - Elevated in utero estrogenic environment increases resistance of mammary tumors to tamoxifen by reversible epigenetic modifications.

Hogan J: - (Ireland) - A novel methodology evaluating high throughout genomic data yields substantial therapeutic and prognostic biomarkers in colorectal cancer.

Horwacik I: - (Poland) - Targeting GD2 ganglioside and aurora A signaling pathways in neuroblastoma - in vitro studies.

Hsiao Y-W: - (Taiwan) - PGE2/HuR/CEBPD axis in macrophages contributes to immunosuppression and inhibits phagocytosis of nasopharyngeal carcinoma.

Hu X: - (China) - Connective tissue growth factor and its receptor integrin αvβ3 in pathogenesis of hypertrophic scar.

Huang M-Y: - (Taiwan) - Significantly decreased the recurrence rate of colorectal cancer patients with Cetuximab treatment by using newly developed KRAS pathway associated molecules analysis Chip.

Hughes A: - (UK) - Paediatric viral infections and neonates.

Hurtado A: - (Norway) - HER2 signaling pathway controls FOXA1 induced proliferation in breast cancer.

Hyodo F: - (Japan) - In vivo tumor redox imaging using magnetic resonance imaging.

Hyun JW: - (Korea) - Epigenetic alteration, cytoplasmic mislocalization of RUNX3 and oxidative stress.

Ishigaki Y: - (Japan) - Role of RNA binding protein in cell cycle progression and centrosome maturation in human tumor cells.

Isoga E: - (Japan) - Prevention of enterohemorrhagic Escherichia coli O157:H7 infection by bacteria composed with intestinal flora.

Januszkiewicz–Lewandowska D: - (Poland) - Expression of MX1, OAS1, PKR (EIF2AK2) and TP53 genes during treatment of chronic HCV patients.

Jia C: - (China) - Anatomic liver resection of segment 6, 7 and 8 is an alternative modality for maximal hepatectomy in the treatment of hepatocellular carcinoma.

Jia S: - (China) - WAVE2, WASP family verprolin-homologous protein 2, down-regulated in gastric cancer indicates lymph node metastasis and cell migration.

Jiang WG: - (UK) - Novel approaches in the management of transcoelomic spread of cancers.

Jin D: - (China) - Parallel detection of circulating K-ras mutation and serum CA19-9 for diagnosis of pancreatic cancer: a meta-analysis.

Jin J: - (China) - Functional analysis of human histone acetyltransferase (hMOF) in tumorigenesis.

Johnson DE: - (USA) - Common genetic alterations in head and neck cancer: the impact of caspase-8 mutations.

Jung I: - (Romania) - Rare variants of gastric carcinoma: An update.

Jura J: - (Poland) - MCPIP1 and clear cell renal cell carcinoma.

Jurecekova J: - (Slovakia) - Association of genetic variants in estrogen receptor α with the prostate cancer risk in Slovak population.

Jurisic V: - (Serbia) - Influence of cytokines on expression cell surface molecule in tumor cells.

Kai C: - (Japan) - A novel strategy of oncotherapy using a recombinant measles virus.

Kaleagasioglu F: - (Turkey) - Alkylphosphocholines and the current anticancer profile of erufosine.

Kalkan R: - (Cyprus) - Molecular genetic markers of glioblastoma multiforme.

Karabulut AB: - (Turkey) - Nutrition or additives role in carcinogenesis.

Karagiannis SN: - (UK) - Engineered IgE antibodies recognising tumour associated antigens: a paradigm for activating immune effector functions against cancer.

Kathawala RJ: - (USA) - TKI's as antagonists of ATP-binding cassette subfamily C member 10 transporter.

Kellie S: - (Australia) - Tyrosine phosphatases as targets in breast cancer.

Kentepozidis N: - (Greece) - Advances in metastatic prostate cancer.

Ketteler R: - (UK) - Targeting the autophagy machinery in cancer.

Khaddour H: - (Romania) - Chemotherapy resistance in cancer cells.

Kim J-M: - (Korea) - N-Myc downstream-regulated gene 2 is an Independent Prognostic Factor in Gallbladder Carcinoma.

Kim J-S: - (Korea) - Cancerous inhibitor of PP2A as a novel regulatory protein of mitotic Plk1 in human cancer cells.

Knox SS: - (USA) - Oncology and biophysics: a systems approach.

Kobayashi KS: - (USA) - Molecular mechanism of regulation of MHC class I genes.

Kominsky SL: - (USA) - CITED2: a potential facilitator of breast cancer bone metastasis.

Kondo T: - (Japan) - Identification of a tumor suppressor GIC-miRNA1 that targets the plasminogen activator system in glioblastoma-initiating cells.

Kondo T: - (Japan) - Proteomics for personalized treatment in sarcoma.

Kontos M: - (Greece) - RFA in the local treatment of breast cancer.

Korkmaz O: - (Turkey) - Primary chondroblastic osteosarcoma in the left atrium.

Koufakis T: - (Greece) - Hunting the gene: Analysis and Meta-analysis of genetic association studies in Oncology.

Kramvis A: - (South Africa) - Hepatitis C in childhood.

Krifa M: - (Tunisia) - An aqueous extract of Limoniastrum guyonianum gall induces anti-tumor effects in melanoma-injected mice via modulation of the immune response.

Krstic-Demonacos M: - (UK) - Determinants of drug and microenvironment response in acute lymphoblastic leukaemia.

Kryschi C: - (Germany) - Semiconductor nanoparticles and gold cluster for radiatiosensitization of cancer and non-cancerous cell lines.

Kulbacka J: - (Poland) - Nanosecond pulsed electric fields (nsPEFs) - modifications and anticancer applications - in vitro study.

Kuo WP: - (USA) - Genome-wide study of salivary microRNAs for detection of oral cancer.

Kuroda K: - (Japan) - Metabolites variation in colon cancer cell line HCT116 treated with antimicrobial peptide FF/CAP18.

Kuznetsov VA: - (Singapore) - Novel strategies of genome data analysis for identification of molecular tumor sub-types and clinical biomarker discovery.

Larsen AK: - (France) - Autocrine signaling plays a major role in the response of colorectal cancer cells to VEGF blockage.

Latruffe N: - (France) - Red wine polyphenol extracts (RWPE) inhibit colon carcinoma cell proliferation in vitro and colonic pre-cancerous lesions in vivo.

Lecat S: - (France) - Plasma membrane translocation of REDD1 governed by G-Protein Coupled Receptors contributes to mTORC1 activation.

Lee MA: - (Korea) - Development of cell therapy for malignant glioma using chemoattract molecules for neural stem cell.

Lee S-H: - (Korea) - Mitigation of asthmatic and atopic inflammation by food/biomaterials.

Lee Y: - (Korea) - Apoptotic protein activation and immune activation of turmeric oil component in vitro and vivo research.

Leung KN: - (China) - Molecular studies on the anti-tumor effects of tryptanthrin on human neuroblastoma.

Leung LK: - (China) - Natural aromatase inhibitors and their potential therapeutic effects on breast cancer.

Li Y: - (Australia) - Preclinical studies of the combination of dual PI3K/Akt/mTOR inhibitors with radiotherapy to overcome radioresistant prostate cancer.

Liagre B: - (France) - Efficiency of dispermidined-protoporphyrin IX mediated dynamic phototherapy on apoptosis of prostate cancer cells.

Liang X: - (China) - TIPE1 induces cell death by negatively regulating Rac-1 activation in hepatocellular carcinoma cells.

Liekens S: - (Belgium) - New targeted agents for selective cancer treatment.

Lin S-R: - (Taiwan) - Rapid method for detecting the KRAS oncogene from Circulating Tumor Cells by using genechip based platform.

Ling L: - (Australia) - The role of cancer stem cells in the development of prostate tumor metastasis.

Lipinska B: - (Poland) - HtrA proteins as possible targets in cancer therapy.

Liu D: - (China) - CD97iso: a novel therapeutic marker for metastatic gastric carcinoma.

Liu Q: - (China) - Biological treatment of retinoblastoma in children.

Liu X: - (China) - Inhibition of cell growth and alterations of cell cycle by natural product SZ-NCI-0819 in ovarian cancer.

Lo Nigro C: - (Italy) - Detection and prognostic role of HPV in head and neck carcinoma.

Lohi H: - (Finland) - Mapping new anxiety genes with the help of man's best friend -dog.

Lombardi P: - (Italy) - Recent advances in antitumour berberine.

Los M: - (Sweden) - Cell cycle regulation in cancer stem cells and iPS cells- the role of PFKFB3.

Lu J: - (China) - Serum microRNA-101-5p as a new biomarker in cirrhosis and its related hepatocellular carcinoma.

Lu Y-J: - (UK) - Novel function of androgen receptor-the regulation of DNA replication and genomic movement.

Ma C: - (China) - Tim-3 fosters HCC progress by regulating tumor associated macrophages.

Macdonald A: - (UK) - Insights into the elusive human papillomavirus E5 oncogene.

Macdonald A: - (UK) - Merkel cell carcinoma polyomavirus- the new kid on the tumour virus block.

Majumdar APN: - (USA) - microRNAs in regulation of colon cancer stem cells.

Malek A: - (Russia) - Tumor-derived exosomal miRNA signalling as a diagnostic/follow up tool and therapeutic target.

Mancinelli R: - (Italy) - The effect of hypoxia on human skeletal muscle: molecular and cellular analysis.

Mancini S: - (Italy) - Increased expression of autophagy-related proteins in human colorectal cancer development and correlation with DNA Microsatellite Stable and Unstable.

Manne U: - (USA) - Biomarker discovery and validation strategies.

Manola KN: - (Greece) - Genetic predisposition to Acute Myeloid Leukemia and its specific chromosomal abnormalities.

Mao X: - (UK) - Population difference in prostate cancer genetic risk and novel predisposition loci.

Marcinkowska E: - (Poland) - Mechanisms of regulation of vitamin D receptor expression by retinoids; implications for differentiation therapy of acute myeloid leukemia.

Maruyama T: - (Japan) - Stem/progenitor cells in the human uterus: implications for uterine tumors.

Mascolo M: - (Italy) - Novel prognostic markers for uveal melanoma.

Massoumi R: - (Sweden) - The role of deubiquitination enzymes in liver fibrosis and cancer.

Matsuda H: - (Japan) - Effects of thermo-therapy on malignant mesothelioma.

Mavragani C: - (Greece) - Autoimmunity and lymphomagenesis: lessons from Sjogren's syndrome.

Mayyas F: - (Jordan) - The significance of circulating endothelin-1 as a predictor of coronary artery disease status and clinical outcomes following coronary artery catheterization.

Mazella J: - (France) - Weakening of human epithelial HT29 cancer cells cohesion by the soluble form of neurotensin receptor-3.

McCubrey JA: - (USA) - Suppressing prostate cancer by targeting NGAL.

Meira DD: - (Brazil) - Molecular oncology: challenges and perspectives.

Melissari E: - (Greece) - Investigation and treatment of HIT/T syndrome.

Min B-M: - (Korea) - ECM-derived bioactive peptides in tissue regeneration.

Mio K: - (Japan) - Conformational variation of the translocon enhancing chaperone SecDF.

Miquel TP: - (Spain) - New therapeutic strategies in triple negative breast cancer (TNBC).

Mitsunaga A: - (Japan) - A new method of endoscopic ultrasonography for determining the depth of early gastric cancer.

Molinari C: - (Italy) - New predictive markers of response to chemoradiotherapy in rectal cancer: microRNA-17-92 and methylation profile.

Molloy TJ: - (Canada) - MicroRNA regulation of radiotherapy sensitivity and resistance in breast cancer.

Moravcikova E: - (Czech Republic) - Differential sensitivity to apoptosome apparatus activation in non-small cell lung carcinoma and the lung.

Mus-Veteau I: - (France) - Patched: a new target for the treatment of adrenocortical carcinoma.

Nakamura T: - (Japan) - The p53-deficient lens tumors may recruit tumor-associated macrophages expressing IDO (indoleamine 2, 3-dioxygenase), which may be modulated by a Kampo (Japanese herbal) medicine Juzentaihoto in transgenic mice.

Naliwajko SK: - (Poland) - Propolis as anti-proliferative and anti-metastatic agent in human Glioblastoma multiforme (U87MG) and diffuse astrocytoma steam like cell lines.

Nardi NB: - (Brazil) - Therapeutic potential of mesenchymal stem cells in regenerative medicine.

Nateri AS: - (UK) - Fbxw7 tumour suppressor gene: cell fate control and signal integration in small intestine and colon.

Neri F: - (Italy) - DNA demethylation in stem cells and cancer development.

Nowak J: - (Poland) - NBN gene expression and cytogenetic changes in irradiated cells with NBN gene mutations.

Ochs MF: - (USA) - Integrating diverse molecular data to identify deregulated pathways in cancer.

Oguri M: - (Japan) - Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation.

Ohlendieck K: - (Ireland) - Proteomic profiling of X-linked muscular dystrophy-associated cardiomyopathy.

Ohlendieck K: - (Ireland) - Proteomics of muscular dystrophy-associated cardiomyopathy.

Okuda K: - (Japan) - Mode of action of bacteriocins against Staphylococcus aureus biofilm.

Orang-Ojong BB: - (China) - Selective estrogen receptor modulators from traditional Chinese medicines as potential source of breast cancer therapy.

Orzechowska E: - (Poland) - Cell-penetrating TAT-BID fusion protein sensitizes cancer cells to apoptosis.

Ozunal ZG: - (Turkey) - Drug development, drug re-positioning in oncology.

Pajic M: - (Australia) - From functional genomics to precision medicine: Using well annotated models to define personalised treatment strategies for pancreatic cancer.

Pan-Hammarström Q: - (Sweden) - Characterisation of the genome of diffuse large B cell lymphoma.

Panda D: - (India) - Microtubule targeted new anticancer agents.

Papadimitriou CA: - (Greece) - The role of angiogenesis and its inhibition in epithelial ovarian cancer.

Patel NA: - (USA) - Alternative splicing of PKCδ during adipogenesis program provides clues for susceptibility to obesity.

Patsavoudi L: - (Greece) - MAb 4C5: A new HSP90 inhibitor possibly to be used in cancer therapeutics.

Pchejetski D: - (UK) - Development of a new epigenetic-based blood test to stratify prostate cancer patients according to risk groups.

Pedicini P: - (Italy) - Kick-off time for accelerated proliferation during the radiotherapy: the hypothesis of stem cells activation.

Pedrosa RC: - (Brazil) - Ascorbate increases Naphthoquinones cytotoxicity, cell proliferation inhibition and tumor growth by induction of oxidative stress.

Pei Z: - (USA) - Microbial link to esophageal adenocarcinoma.

Peng F: - (USA) - Altered copper metabolism: novel theranostic biomarker for prostate cancer imaging and therapy.

Pesic M: - (Serbia) - Targeting multi-drug resistance in cancer: What are the options?

Peyron J-F: - (France) - Targeting leukemia metabolism or essential amino acid uptake shows anti-tumoral activity in PTEN-deficient T-cell mouse lymphomas and T-ALL/T-LL human cells.

Piwocka K: - (Poland) - BRCA1 translation in leukemia: role of mRNA binding proteins.

Piyathilake C: - (USA) - Diet-related epigenetic biomarkers of cervical cancer risk.

Pizon M: - (Germany) - The formation of tumor spheres from peripherally circulating cells and their molecular characterization.

Plant N: - (UK) - Predicting the metabolic landscape of poor prognosis breast cancer.

Pollard JP: - (UK) - The role of fumarate as an oncometabolite.

Ponglikitmongkol M: - (Thailand) - Human papillomavirus type 16 promotes cervical cancer severity.

Porichis F: - (USA) - HIV research and children.

Priel E: - (Israel) - Novel telomerase activators in ageing and age related diseases.

Prigen C: - (France) - Aurora-A kinase activity and cancer.

Prioleau M-N: - (France) - Regulation of the spatiotemporal program of DNA replication in vertebrates.

Provenzani A: - (Italy) - Novel insights about the NAMPT inhibitor FK866 mechanism of action in cancer cells.

Przybyla BD: - (USA) - Molecules involved in cross-talk between bone marrow and ablated tumor as a potential markers for monitoring and predicting effectiveness of radio- and thermotherapies of solid tumors.

Pützer B: - (Germany) - Crossing the border: DNp73 in cancer metastasis.

Ramayya MS: - (USA) - Human steroidogenic factor-1: Putative suppressor of epithelial ovarian cancer.

Ranson M: - (Australia) - Inhibition of cancer growth and metastasis by serpinb2, a specific regulator of urokinase.

Ratajczak MZ: - (Poland) - Identification of the extracellular nucleotides ATP and UTP as novel underappreciated pro-metastatic chemotactic factors for human lung cancer cells.

Raviraj V: - (Australia) - Reelin as a tumour suppressor in head and neck squamous cell carcinomas.

Ray A: - (USA) - Epigenetic and DNA conformation mediated regulation in breast cancer.

Ray BK: - (USA) - Molecular mechanism regulating angiogenesis dormancy in breast cancer.

Refinetti P: - (Switzerland) - Mapping cell lineage growth in human tumors using somatic mitochondrial mutations.

Rennie P: - (Canada) - A new class of estrogen receptor-α (ERα) inhibitors to treat tamoxifen-resistant breast cancers.

Rezaei V: - (Iran) - Assignment of protein sequences to their respective families based on the dependency between them.

Rezano A: - (Japan) - DSS1 as a prognostic marker for breast cancer progression and patient relapse-free survival.

Richard D: - (Australia) - hSSB1, a critical DNA repair protein in cancer development.

Rivard N: - (Canada) - Understanding the dual nature of SHP-2 in colorectal cancer.

Ropert C: - (Brazil) - The yin and the yang of the use of TLR agonist in cancer therapy.

Rosen K: - (Canada) - Oncogenes as inhibitors of cancer cell death.

Rudner J: - (Germany) - Regulation of Mcl-1 stability: Impact on cancer cell survival and resistance radiotherapy.

Russo J: - (USA) - The double edge of pregnancy in the prevention and risk of breast cancer.

Ruvolo PP: - (USA) - Role for protein phosphatase 2A in drug resistance in leukemia.

Porichis F: - (USA) - Molecular mechanism regulating angiogenesis dormancy in breast cancer.

Saczko J: - (Poland) - Metastatic cancers treated by electrochemotherapy with cisplatin and Betulinic acid - in vitro study.

Sagerström CG: - (USA) - Prep/Meis and Pbx cofactors poise promoters for activation by Hox proteins.

Sagnou M: - (Greece) - Novel natural product-based agents for early diagnosis and therapeutic application in multi-drug resistant tumors.

Sampanis N: - (Greece) - Acute kidney injury induced by oxaliplatin: A case report and review of the literature.

Sarkar S: - (USA) - Epigenetic changes in cancer cells and development of a combination therapy.

Sasayama T: - (Japan) - Cerebrospinal fluid interleukin-10 is associated with molecular subtype, tumor-associated macrophage infiltration and STAT3 activation in primary central nervous system diffuse large B-cell lymphoma.

Sato C: - (Japan) - Atmosphere scanning electron microscopy of Neuron differentiation and phagocytosis of immuno-dendritic cells.

Scutti J: - (Brazil) - SOCS-1 derived peptides protection against malignant melanoma.

Semczuk A: - (Poland) - Role of clinico-prognostical features in patients affected by uterine carcinosarcomas.

Schwartz B: - (Israel) - The effect of the adipose tissue on colon cancer cell metabolism and tumor growth.

Sen E: - (India) - Targeting oxidative stress in glioblastoma: Implications in therapy.

Sena P: - (Italy) - Induction of cellular responses to oxidative stress in HT29 colon cancer cells treated with metphormin.

Sevim H: - (Turkey) - Contribution of NG2 to drug resistance in glioblastoma.

Shaw P-C: - (China) - Nucleophosmin interacts with PinX1 and this interaction attenuates the PinX1 inhibition on telomerase activity.

Shen C: - (China) - Surgical treatment of tumors in Vena Cava.

Singer J: - (Austria) - Comparative oncology: Novel approaches.

Shenoy SPR: - (USA) - Mechanisms regulating Akt-mediated endothelial-barrier function.

Shenoy SPR: - (USA) - TGFb signaling in prostate cancer epithelial-to-mesenchymal transition.

Shi Q: - (China) - Exceeding giant hemangima of liver: non-surgery treatment with interventional ultrasound.

Shia W-C: - (Taiwan) - Evaluations of neo-adjuvant chemotherapy responses in breast cancer patients using vascularization analysis.

Shin MK: - (Korea) - P53 protein expression, BRAF(V600E) mutation and their clinicopathologic significance in papillary thyroid carcinomas.

Shiraki K: - (Japan) - The emerging role of Toll-like receptors in gastrointestinal cancers.

Shiraki K: - (Japan) - The emerging role of Toll-like receptors in gastrointestinal cancers.

Shridhar V: - (USA) - The link between lipid droplets and autophagy in ovarian cancer.

Sidthipong K: - (Japan) - Suppression of cellular invasion by novel NF-kappaB inhibitor Exo-ene EQ in ovarian carcinoma cells.

Sifakis S: - (Greece) - Cell-free fetal DNA in pregnancy complications and non-invasive prenatal diagnosis.

Signorelli SS: - (Italy) - Inflammation and chronic arterial disease.

Singh RK: - (USA) - CXCR2 signaling in tumor progression and metastasis.

Sitcheran R: - (USA) - The non-canonical NF-kappaB signaling pathway is a key driver of brain tumor pathogenesis.

Sologub VK: - (Russia) - Different properties of anti-RNP Mab’s for Rabies Virus.

Sone H: - (Japan) - PAMAM particles induce fetal toxicology and predictive carcinogenicities.

Song Y: - (China) - t (8,17)(q22, q21), A new chromosome translocation found in an acute promyelocytic leukemia patient.

Song Z: - (China) - Inhibition of VEGF agents therapy with or without docetaxel as first-line chemotherapy for castration-resistant prostate cancer: a meta-analysis of four randomized controlled trials.

Song Z: - (China) - A kind of PSA management software can be used for clinical and application.

Soucek P: - (Czech Republic) - Pharmacogenetics of breast carcinoma.

Souchelnytskyi S: - (Sweden) - Personalization of cancer treatment with functional molecular diagnostic.

Soufla G: - (Greece) - Molecular aspects/genetic predisposition to Heparin Induced Thrombocytopenia (HIT/T syndrome).

Stark LA: - (UK) - Nucleolar stress: a link between CDK4 inhibition, stimulation of the NF-κB pathway and the anti-tumour activity of aspirin.

Steelman LS: - (USA) - Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer.

Stephenson S-A: - (Australia) - Eph’ective signaling in cancer: Understanding the complex roles of EphB4 in oncogenesis and tumour suppression.

Su X: - (China) - The mechanism research of bioactive peptide synergistic chemotherapy on the sensitization of gastric cancer cells.

Su Y-H: - (USA) - Development of a urine DNA test for liver cancer screening.

Subramani V: - (India) - Biologically conformal treatment approaches in radiation oncology: role of molecular imaging biomarker.

Sugimoto S: - (Japan) - Fine structures of biofilms in solution visualized by atmosphere scanning electron microscopy.

Sukhotnik I: - (Israel) - The role of Wnt/β-catenin signaling in enterocyte turnover during methotrexate-induced intestinal mucositis in a rat.

Sun L: - (USA) - Novel strategy for the treatment of metastatic and castrate resistant prostate cancer.

Suzuki-Karasaki Y: - (Japan) - Targeting mitochondrial fission/fusion dynamics: a novel approach for selective killing of cancer cells.

Swart AC: - (South Africa) - The metabolism of adrenal 11β-hydroxyandrostenedione – novel pathways in prostate cancer.

Swart P: - (South Africa) - Modulatory effects of Salsola tuberculatiformis Botch. on UVB–induced inflammation in skin: Implications for skin cancer.

Takács-Vellai K: - (Hungary) - Characterizing the role of the Nm23 homolog NDK-1 in cell migration and apoptotic engulfment.

Takahashi R: - (Japan) - Identification of microRNA-27b as a master regulator generating breast cancer stem cells.

Takahashi T: - (Japan) - Protective effect of ulinastatin on hemorrhagic shock-induced acute lung injury.

Tanaka A: - (Japan) - Roles of nuclear factor-κB in both intrinsic and acquired resistance against endocrine therapy in breast cancer.

Tanaka K: - (Japan) - Glutaminase-mediated metabolic pathway involves glioblastoma resistance to mTOR-targeted therapies.

Tang DG: - (USA) - Prostate cancer stem cells and therapy resistance.

Tang SC: - (USA) - Personalized breast cancer care, the future is here.

Tanic N: - (Serbia) - Genomic instability in patients with malignant glioma: identification of novel genetic alterations associated with the disease.

Tata AM: - (Italy) - Roles of muscarinic receptors in tumors: possible therapeutic implications.

Tatsuta T: - (Japan) - A leczyme which has both lectin and ribonuclease activity causes a cancer-selective induction of apoptosis.

Telang NT: - (USA) - Preventive efficacy of the non-steroidal anti-inflammatory drug Sulindac on cell culture models for genetically predisposed early onset colon cancer.

Tenti E: - (Italy) - Paclitaxel and skin toxicity in patients with breast cancer.

Tian B: - (China) - Metabolic characteristics in a rat model of chronic pancreatitis by using of high-resolution magic-angle spinning nuclear magnetic resonance spectroscopy (HR-MAS NMR).

Tian Y: - (China) - The mRNA expression of HOXA10 gene in glioma.

Timpson P: - (Australia) - Imaging anti-invasive drug targeting in live tumours using intravital biosensors.

Tittarelli A: - (Chile) - Gap junction intercellular communications modulate anti-tumor natural killer cytotoxic capacity.

Trepant A-L: - (Belgium) - Stem cells in glioblastoma.

Trigatti B: - (Canada) - High density lipoprotein signaling in macrophages and its role in atherosclerosis protection.

Tsoutsou PG: - (Switzerland) - Emerging concepts on breast cancer radiotherapy: Tailoring strategy to tumor biology.

Umezawa K: - (Japan) - Inhibition of cancer cell invasion by bioactive metabolites.

Vaitkienė P: - (Lithuania) - Gene expression and function-based identification of biomarkers for diagnosis of glioma malignancies.

Von Gunten S: - (Switzerland) - Altered surface glycosylation with expression of Siglec-7/-9 ligands protects tumors from NK cell immunosurveillance.

Voskoboinik I: - (Australia) - Regulation of cytotoxic lymphocyte function in health and disease.

Wagner W: - (Germany) - Patients' satisfaction with different modalities of prostate cancer therapy.

Wang H-X: - (China) - Rational options in breast cancers: how molecular understanding informs treatment.

Wang J-M: - (Taiwan) - The roles of transcription factor CCAAT/enhancer binding protein delta in tumorigenesis.

Wang L: - (China) - FasL gene -844T/C mutation of esophageal cancer in South China and its clinical significance.

Wang R-A: - (China) - How is cancer nurtured: carcinogenesis by stem cell misplacement, a new cancer theory and its implications.

Wang W: - (China) - Epithelial-mesenchymal transition regulated by EphA2 contributes to vasculogenic mimicry formation of head and neck squamous cell carcinoma.

Wang X: - (China) - Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines.

Wang X: - (China) - Reversal effects of tetramethylpyrazine on multidrug resistance in hepatocellular carcinoma cells BEL-7402/ADM by inhibiting calcium pathway.

Wang X: - (China) - The study of anti-aging of Zishenyigan pills in vivo and vitro.

Wang Y: - (China) - Localizing IDH1 mutation in low-grade gliomas.

Wang Z: - (China) - Rac1 functions in cancer.

Watari I: - (Japan) - Changes in the expression of incretin receptors in a mouse osteoblastic cell line in response to various glucose concentrations.

Weinhäusel A: - (Austria) - Immunopoteomics: protein and peptide microarrays for defining serum-IgG signatures for cancer diagnostic.

Wells CM: - (UK) - PAK family kinases - molecular targets in cancer metastasis.

Williams JL: - (USA) - Impact of genetics/epigenetics on colon cancer development and response to chemopreventive agents.

Wingert R: - (USA) - Genetic regulatory networks that direct nephron development in the zebrafish kidney.

Wong C: - (USA) - Opioid free robot-assisted laparoscopic prostatectomy.

Wu W: - (China) - miR-612 suppresses the stemnesses of hepatocellular carcinoma.

Wu Z: - (China) - Differential effects of miR-34c-3p and miR-34c-5p on glioma cells proliferation, apoptosis and invasion.

Xiao X: - (China) - Paris Saponin II inhibits angiogenesis and tumorigenicity of human ovarian cancer cells through NF-kappaB signaling following reduction of the VEGF expression.

Xie X: - (China) - "VISA-MiRNA" nanoparticles targeting to breast cancer stem cells.

Xu H: - (China) - IGF-1 related pathways and high-fat diet promotion of TRAMP mouse prostate cancer progression.

Xu X: - (China) - A genome annotation focused on miRNA regulation elements in a model of Esophageal squamous cell carcinoma.

Yamada K: - (Japan) - The optimal timing of Strontium-89 combing with zoledronic acid for Japanese breast cancer patients with painful bone metastases.

Yamada Y: - (Japan) - Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals.

Yamamoto N: - (Japan) - Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility.

Yan C: - (USA) - Stat3 downstream gene product chitinase 3-Like 1 is a biomarker of inflammation-induced lung cancers.

Yang M: - (China) - Exosomal shuttled microRNA: a new target for breast cancer therapy.

Yang S: - (China) - Identification of new roles of HIF-2 alpha in the development of hepatocellular carcinoma.

Yao L: - (China) - A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumor angiogenesis and metastasis.

Ye Q: - (China) - Estrogen signaling in breast cancer.

Yoshinaga T: - (Japan) - Angiopoetin-like protein 2 is a potential biomarker for gastric cancer.

Yu D-Y: - (Korea) - Roles of peroxiredoxin I and II in cancer development and characterization of transcription factors regulating their expression and relevant signaling.

Yu X: - (China) - Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China.

Yu Y: - (China) - FSH-TRPC3 interaction positively regulates the proliferation of ovarian cancer cells.

Yun Y: - (China) - The role of acidic leucine-rich nuclear phosphoprotein 32 family member B (ANP32B) in leukemic cell apoptosis and differentiation.

Zaravinos A: - (Cyprus) - Altered metabolic pathways in clear cell renal cell carcinoma.

Zaravinos A: - (Cyprus) - GSEA of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma.

Zaravinos A: - (Cyprus) - Novel miRNA profiles specific for renal cell carcinomas and upper tract urothelial carcinomas.

Zeng H: - (China) - Complex interaction of PTEN and BCRP/ABCG2 in leukemia.

Zhang J: - (China) - Molecular staging and personalized postoperative treatment of non-small cell lung cancer.

Zhang S: - (China) - Mitigation of radiation-induced skin injury by overexpression of Nrf2.

Zhang T: - (USA) - The reversal of ABCG2-mediated multidrug resistance (MDR) with PD153035.

Zhu J: - (China) - The unexpected Journey of MSCs in tumor microenvironment - analysis of the biological characteristics of MSCs in tumor microenvironment.

Zhu Y: - (China) - The application of sequence analysis in the control for human infection with H7N9 virus.

Zoumpoulidou G: - (UK) - Critical requirement for the Tripartite motif protein 27 (TRIM27) in cancer development.

Zuo D: - (China) - On the interactions between the transplantation of the bone marrow mesenchymal stem cells and regulatory T cells for treatment of experimental Colitis.

Zweytick D: - (Austria) - Antitumor peptides derived of human Lactoferricin as cancer therapy targeting the membrane lipid phosphatidylserine exposed by malignant melanoma and glioblastoma.

Back to Top